Will FDA Fixes Spur Innovation?
Congress, Obama offer strategies to reduce regulatory roadblocks to new breakthroughs.
Is There Gold in the DNA Selfie?
Pharma jumps on board personal genomics train-at least for test drive-but will journey ultimately help transform treatment or stall out as just another fad?
23andMe’s Double Play: Making Science & Patients Partners
Pharm Exec profiles patient DNA partnering advocate 23andMe, which recently struck data deals with a pair of big Pharmas, thrusting the debate over personal genomics and patient treatment back into high gear.
Behind the Boom in Biotech
Tomorrow’s Selling Strategies: Invest & Test
A new PwC survey reveals a strong need to fully embrace alternative commercial methods-not in a blind frenzy but through careful evaluation of which new sales strategies have true innovative potential.
Have Your Eggs, and Your Statin (and Your PCSK9 inhibitor, too?)
The cholesterol-fighting market is back with a vengeance; plenty of complications in store
STAMPing on MAPPs: Is Europe Trapped Again By Division?
New EU group could ultimately end up handcuffing much-needed efforts to modernize drug authorization.
Our Love Affair with Buzzwords
How pharma can finally put true meaning behind its juiced-up jargon and turn the bluster into reality.
